B & Y Technologies has been working on a novel immunotherapy for treatment of chronic diseases including type 2 diabetes mellitus, metabolic syndrome, obesity, hypothyroidism, osteoporosis, osteoarthritis, infertility, aging and more for 17 years.
You must wonder how come our immunotherapy can treat so many major chronic major diseases? The key is the human brain. The aging of brain, in particular hypothalamus and pituitary gland leads to weakened neuro-endocrine system. The malfunction of the neuro-endocrine system leads to many problems in energy metabolism, thyroid gland, adrenal gland, liver, bone density, reproduction, etc. These chronic diseases have limited treatment options with limited efficacy, because the root-causes of these diseases are not adequately addressed.
The importance of brain for biological functions is well known, however, not everybody knows the fact that aging of brain is the root cause of so many chronic diseases, and more importantly, nobody except us knows how to regulate the aging process of brain.
Small-sized, proof-of-principle clinical trials have been conducted in China to prove the immunotherapy is safe and effective. A few hundreds of patients have so far been treated with the immunotherapy with favorable results.
We would like to raise 20 millions of USD for this round of financing and plan to use the funds to complete pre-IND studies for 1.2m, to conduct two phase I and two phase II clinical trials in America, which would cost 15m. The remaining 3.8m is for general administration.
All work mentioned above will be done in 5 years and then our investors would have choice of either continuing to stay with us or exiting at an IPO.